Cytostatic drug resistance. Role of phase-I daunorubicin metabolism in cancer cells.
Soldan
M
M
Department of Pharmacology and Toxicology, Philipps-University of Marburg, Germany.
Ax
W
W
Plebuch
M
M
Koch
L
L
Maser
E
E
D000429:Alcohol Oxidoreductases / Q000235:genetics / Q000378:metabolism*; D000449:Aldehyde Reductase / Q000235:genetics / Q000378:metabolism*; D000074408:Aldo-Keto Reductases; D000903:Antibiotics, Antineoplastic / Q000378:metabolism*; D003630:Daunorubicin / Q000378:metabolism*; D019008:Drug Resistance, Neoplasm; D006801:Humans; D009369:Neoplasms / Q000201:enzymology*; D013274:Stomach Neoplasms; D014162:Transfection; D014407:Tumor Cells, Cultured
D000903:Antibiotics, Antineoplastic; D000429:Alcohol Oxidoreductases; D000074408:Aldo-Keto Reductases; C019642:alcohol dehydrogenase (NADP+); D000449:Aldehyde Reductase; D003630:Daunorubicin